Pronethalol, an adrenergic beta-receptor antagonist, has been used successfully in the treatment of supraventricular and ventricular arrhythmias (Stock and Dale, 1963; Johnstone, 1964) . The usefulness of pronethalol has been limited by its carcinogenic activity in mice and its unpleasant side-effects in man. It has been replaced by propranolol (inderal; 1 -isopropylamine -3 -(1 naphthyloxy) -2 -propanol hydrochloride), which has the same beta-sympathetic blocking action but is free from carcinogenic activity in mice and has a much wider therapeutic ratio (Hamer et al., 1964; Chamberlain and Howard, 1964 diogram three episodes of ventricular tachycardia were recorded, lasting 2, 3, and 10 seconds, respectively. The ventricular rate during the paroxysms was 214 a minute. The sinus complexes showed isoelectric S-T segments and T waves of normal polarity. There was no evidence of ischemic heart disease or ventricular hypertrophy. During the paroxysms the pulse was impalpable. The last episode, which lasted 10 seconds, was accompanied by numbness of the upper limbs.
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It was concluded that the bouts of syncope and parssthesise of the upper limbs were caused by paroxysms of ventricular tachycardia.
Treatment with propanolol (inderal) 40 mg. thrice daily was commenced. The patient was examined 2, 4, and 20 weeks after starting therapy. On these examinations the pulse varied between 48 and 56 a minute and the blood pressure between 150/85 and 140/80 mm. Hg. Further cardiograms showed sinus bradycardia but no further episodes of ventricular tachycardia and no ventricular premature beats. He had no further attacks of syncope. One may conclude that propranolol had prevented paroxysms of ventricular tachycardia.
Comment
The beta receptors have predominantly inhibitory functions but have an excitatory effect on the myocardium. Pronethalol, synthesized in 1962, is an adrenergic beta-receptor antagonist, free from intrinsic sympathomimetic activity. Pronethalol, given intravenously to produce complete beta-receptor blockade, has no effect on cholinergic response (Benfey and Grillo, 1963 (Murray, McKnight, and Davis, 1963) .
Use of pronethalol was discontinued after it was found to be a carcinogen in mice. Propranolol (inderal), a close chemical analogue of pronethalol, has been introduced. Propranolol has no carcinogenic activity in mice and its therapeutic ratio is 10-20 times greater than pronethalol. In animal experiments propranolol has been found to produce bradycardia and a marked antagonism of isoprenaline tachycardia. Intravenous injection produces no change in myocardial tension, but blocks the inotropic effects of stellate ganglion stimulation and isoprenaline. Stock and Dale (1963) have shown that pronethalol abolishes the arrhythmias due to digitalis intoxication, including paroxysmal atrial tachycardia with block. They also reported good results in the treatment of multifocal ventricular ectopic beats. Suppression of digitalis-induced arrhythmias has also been achieved by propranolol.
In atrial flutter or tachycardia propranolol induces a reduction in the ventricular rate when used alone, and reduces the ventricular rate in the fully digitalized patient.
In atrial fibrillation propanolol causes slowing of the ventricular rate and further slowing in the already digitalized patient (Rowlands, Howitt, and Markham, 1965) . The drug is of value with an uncontrolled ventricular rate and obstruction at the mitral valve.
The action ofpropranolol in repetitive paroxysmal ventricular tachycardia is similar to that of pronethalol (Stock and Dale, 1963) . It causes a reduction in the percentage of ectopic beats and in the over-all heart rate, without completely suppressing the ectopic beats.
Propranolol has been used to abolish a large variety of the arrhythmias occurring during aneesthesia (Johnstone, 1964) . Prophylactic use of propranolol has been suggested in premedication of patients who have frequent ectopic beats to reduce the risk of ventricular arrhythmias during the subsequent antesthesia.
Propranolol has been used successfully in persistent ventricular fibrillation. Sloman, Robinson, and McLean-(1965) 
